1. International Conference on Harmonization (ICH) (2002) guidelines. Q3A (R) impurities in New Drug Substances; ICH guidelines: Geneva, Switzerland
2. International Conference on Harmonization (ICH) (1996) guidelines. Q2B validation of analytical procedure: Methodology, Geneva, Switzerland, November 6
3. Ambati VRR, Garaga S, Dandala R, Meenakshisunderam S (2007) Process for the preparation of substantially pure (2S,3S,5S)-5-amino-2-N,N-dibenzylamino-3-hydroxy-1,6-diphenylhexane. US Patent 8236991 B.
4. Stoner EJ, Cooper AJ, Dickman DA, KolaczKowski L, Lallaman JE, Liu JH, Oliver-Shaffer PA, Patel KM, Paterson JB, Plata DJ, Riley DA, Sham HL, Stengel PJ, Tien JH (2000) J Org Process Res Dev 4:264–269
5. Sham HL, Betebenner DA, Herrin T, Kumar G, Saldivar A, Vasavanonda S, Molla A, Kempf DJ, Plattner JJ, Norbeck W (2001) Bioorg Med Chem Lett 11:1351